Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

As probiotics use grows for gut health, VSL#3 has designations for specific GI issues

18.11.2011
VSL#3, classified as medical food, is designated for the dietary management of UC, ileal pouch and IBS

As clinical studies continue to validate the use of probiotics to help promote general gastrointestinal health, a growing U.S. market1 for probiotics indicates that the U.S. healthcare community and consumers alike are recognizing the value of these beneficial microorganisms.

However, because most probiotics are classified as dietary supplements, directing patients to the best probiotic for their individual needs can be challenging. And, as the category matures, one probiotic preparation -- VSL#3 -- stands apart and ahead because it is not a supplement; it has been classified as a refrigerated medical food designated for the dietary management of three major gastrointestinal conditions: Ulcerative Colitis, Ileal Pouch and Irritable Bowel Syndrome (IBS).

The World Health Organization (WHO) defines probiotics as "live microorganisms which, when administered in adequate amounts confer a health benefit to the host." But research also shows that probiotics are not "one size fits all."

"As the amount of research in the field of probiotics increases, clinical evidence continues to indicate that not all probiotics are the same; probiotic activity is strain-specific and unique, and some strains can have antagonistic or synergistic activities when mixed together," said Marc Tewey, vice president, commercial operations, at Sigma-Tau Pharmaceuticals, Inc., manufacturer of VSL#3. "VSL#3 is formulated with a precise mix of eight proprietary strains of live bacteria, and the result is a probiotic medical food so potent, it must be used under medical supervision and must be shipped and sold as a refrigerated product."

What are medical foods?

According to the FDA, medical foods are:

Specially formulated and processed products for the partial or exclusive feeding of a patient by means of oral intake or parenteral tube feeding
For dietary management of patients with special medically determined nutrient requirements that cannot be achieved by diet alone
Designed to provide nutritional support specifically modified for the management of the unique nutrient needs
Only for use under medical supervision
Only for a patient receiving active medical care on a recurring basis for the use of the medical food

The VSL#3 line of products contain between 112.5 billion and 900 billion live, colony-forming units (CFU), the large numbers of which make them the most potent brand of probiotics available and require the product to be refrigerated. VSL#3 utilizes a synergistic combination of diverse strains of bacteria including: Streptococcus thermophilus, Bifidobacteria longum, Bifidobacteria infantis, Bifidobacteria breve, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei and Lactobacillus delbrueckii subsp. Bulgaricus. Clinical studies using VSL#3 and published in notable journals, such as Gut, Gastroenterology and the American Journal of Gastroenterology have indicated that it colonizes the GI tract with beneficial bacteria, and in doing so, forms an intestinal barrier, which may help protect the GI tract and promote the absorption of nutrients.

"One of the main goals of physicians whose patients are living with these chronic diseases is to lengthen the periods between symptom 'flares' as much as possible," said Tewey. "Studies show that incorporating the use of this type of dietary therapy alongside traditional drug therapies can be an effective step in achieving that goal for many who suffer from these debilitating conditions."

VSL#3 is one of the few probiotic preparations supported by Level 1 (double-blind, placebo-controlled) scientific data, and has been the subject of a collection of more than 80 studies that have demonstrated its efficacy, specifically in the dietary management of IBS, Ulcerative Colitis and Ileal Pouch. It is the only probiotic recognized as an effective tool in the dietary management of pouchitis by the American College of Gastroenterology2 and by the Cochrane Review3 for the treatment and prevention of pouchtis after ileal pouch-anal anastamosis for chronic ulcerative colitis.

VSL#3 products are available online at www.vsl3.com, as well as behind the pharmacy counter at pharmacies nationwide. They come in three formulations: VSL#3 DS prescription-only packets, VSL#3 OTC packets and VSL#3 OTC capsules. Physicians and pharmacists interested in additional information about the product can call 1-866-634-2765 and consumers may call 1-866-GET-VSL3 or visit www.vsl3.com for more information.

1 Source: "U.S. Digestive Health Enzymes, Prebiotics & Probiotics Market (2010 – 2015)" Markets and Markets, July 4, 2011

2Kornbluth, A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee.; Practice Parameters Committee of the American College of Gastroenterology. AM J. Gastroenterol. 2010 Mar; 105(3):501-23

3Holubar SD et al., (Review) The Cochrane Library 2010, Issue 6.

Nicole Egan | EurekAlert!
Further information:
http://www.rlapr.com

More articles from Health and Medicine:

nachricht A step closer to cancer precision medicine
14.11.2019 | University of Helsinki

nachricht Can 'smart toilets' be the next health data wellspring?
14.11.2019 | Morgridge Institute for Research

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New opportunities in additive manufacturing presented

Fraunhofer IFAM Dresden demonstrates manufacturing of copper components

The Fraunhofer Institute for Manufacturing Technology and Advanced Materials IFAM in Dresden has succeeded in using Selective Electron Beam Melting (SEBM) to...

Im Focus: New Pitt research finds carbon nanotubes show a love/hate relationship with water

Carbon nanotubes (CNTs) are valuable for a wide variety of applications. Made of graphene sheets rolled into tubes 10,000 times smaller than a human hair, CNTs have an exceptional strength-to-mass ratio and excellent thermal and electrical properties. These features make them ideal for a range of applications, including supercapacitors, interconnects, adhesives, particle trapping and structural color.

New research reveals even more potential for CNTs: as a coating, they can both repel and hold water in place, a useful property for applications like printing,...

Im Focus: Magnets for the second dimension

If you've ever tried to put several really strong, small cube magnets right next to each other on a magnetic board, you'll know that you just can't do it. What happens is that the magnets always arrange themselves in a column sticking out vertically from the magnetic board. Moreover, it's almost impossible to join several rows of these magnets together to form a flat surface. That's because magnets are dipolar. Equal poles repel each other, with the north pole of one magnet always attaching itself to the south pole of another and vice versa. This explains why they form a column with all the magnets aligned the same way.

Now, scientists at ETH Zurich have managed to create magnetic building blocks in the shape of cubes that - for the first time ever - can be joined together to...

Im Focus: A new quantum data classification protocol brings us nearer to a future 'quantum internet'

The algorithm represents a first step in the automated learning of quantum information networks

Quantum-based communication and computation technologies promise unprecedented applications, such as unconditionally secure communications, ultra-precise...

Im Focus: Distorted Atoms

In two experiments performed at the free-electron laser FLASH in Hamburg a cooperation led by physicists from the Heidelberg Max Planck Institute for Nuclear physics (MPIK) demonstrated strongly-driven nonlinear interaction of ultrashort extreme-ultraviolet (XUV) laser pulses with atoms and ions. The powerful excitation of an electron pair in helium was found to compete with the ultrafast decay, which temporarily may even lead to population inversion. Resonant transitions in doubly charged neon ions were shifted in energy, and observed by XUV-XUV pump-probe transient absorption spectroscopy.

An international team led by physicists from the MPIK reports on new results for efficient two-electron excitations in helium driven by strong and ultrashort...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

High entropy alloys for hot turbines and tireless metal-forming presses

05.11.2019 | Event News

Smart lasers open up new applications and are the “tool of choice” in digitalization

30.10.2019 | Event News

International Symposium on Functional Materials for Electrolysis, Fuel Cells and Metal-Air Batteries

02.10.2019 | Event News

 
Latest News

Theoretical tubulanes inspire ultrahard polymers

14.11.2019 | Materials Sciences

Can 'smart toilets' be the next health data wellspring?

14.11.2019 | Health and Medicine

New spin directions in pyrite an encouraging sign for future spintronics

14.11.2019 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>